Hotline for Health Services for Displaced Lebanese 1787
Hotline for the Patient Admission to Hospitals 01/832700
COVID-19 Vaccine Registration Form covax.moph.gov.lb
MoPH Hotline 1214
Are you a new member? Sign up now
 
Let us help you
Read about the latest topics.

Drugs Public Price List


Lebanon National Drugs Database

 
Drugs Prices According to the Exchange Rate Issued on 5/2/2024
  • Drugs Public Price List according to decision no. 119/1 published in the Official Gazette of 30/01/2020
    
Date Exchange Rate Drugs Public Price
16/7/2024 89,500 LBP Drugs Public Price List
13/6/2024 89,500 LBP Drugs Public Price List
27/5/2024 89,500 LBP Drugs Public Price List
14/5/2024 89,500 LBP Drugs Public Price List
17/4/2024 89,500 LBP Drugs Public Price List
21/3/2024 89,500 LBP Drugs Public Price List
20/3/2024 89,500 LBP Drugs Public Price List
7/3/2024 89,500 LBP Drugs Public Price List
12/2/2024 90,000 LBP Drugs Public Price List
5/2/2024 90,000 LBP Drugs Public Price List
  • Non Subsidized Drugs List issued on 1/2/2023 by Decision No. 119/1 of 26/1/2023, in Particular Article 1 that Stipulates: "The Ministry of Public Health Issues on a daily Basis an Index for the Prices of Unsubsidized Medicines According to the US Exchange Rate on the Parallel Market. The Prices For the Public Shall be in Lebanese Pounds." (You can check the updated prices in the Drugs Public Price List)
Date Non Subsidized Drugs
16/7/2024 Non subsidized Drugs List
13/6/2024 Non subsidized Drugs List
14/5/2024 Non subsidized Drugs List
17/4/2024 Non subsidized Drugs List
21/3/2024 Non subsidized Drugs List
20/3/2024 Non subsidized Drugs List
7/3/2024 Non subsidized Drugs List
12/2/2024 Non subsidized Drugs List
5/2/2024 Non subsidized Drugs List
  • The list of medicines covered by Resolution 945/1 by Decision No. 119/1 of 26/1/2023, in Particular Article 1 that Stipulates: "The Ministry of Public Health Issues on a daily Basis an Index for the Prices of Unsubsidized Medicines According to the US Exchange Rate on the Parallel Market. The Prices For the Public Shall be in Lebanese Pounds."
 
Date Exchange Rate Medicines covered by Resolution 945/1
16/7/2024 89,500 LBP List of medicines covered by Resolution 945/1
13/6/2024 89,500 LBP List of medicines covered by Resolution 945/1
27/5/2024 89,500 LBP List of medicines covered by Resolution 945/1
14/5/2024 89,500 LBP List of medicines covered by Resolution 945/1
17/4/2024 89,500 LBP List of medicines covered by Resolution 945/1
21/3/2024 89,500 LBP List of medicines covered by Resolution 945/1
20/3/2024 89,500 LBP List of medicines covered by Resolution 945/1
7/3/2024 89,500 LBP List of medicines covered by Resolution 945/1
12/2/2024 90,000 LBP List of medicines covered by Resolution 945/1
5/2/2024 90,000 LBP List of medicines covered by Resolution 945/1
 
 
  • List of conversion of authorized prices of the imported medicine products to public prices in Lebanon, in Lebanese pound according to the following foreign currency rates (FOB)
  • List of conversion of authorized prices of the imported medicine products to public prices in Lebanon, in Lebanese pound according to the following foreign currency rates (FOB)
  • List of conversion of authorized prices of the imported medicine products to public prices in Lebanon, in Lebanese pound according to the following foreign currency rates (CIF)
  • List of conversion of authorized prices of the imported medicine products to public prices in Lebanon, in Lebanese pound according to the following foreign currency rates (CIF)
  • List of conversion of authorized prices of the imported medicine products to public prices in Lebanon, in Lebanese pound according to the following foreign currency rates (Locally Manufactured)
  • List of conversion of authorized prices of the imported medicine products to public prices in Lebanon, in Lebanese pound according to the following foreign currency rates (Locally Manufactured)
  • List of conversion of authorized prices at Hospital of the imported medicine products (Injectable Drugs-Category E1) to public prices in Lebanon, in Lebanese pound according to the following foreign currency rates
  • List of conversion of authorized prices at Hospital of the imported medicine products (Injectable Drugs-Category E2) to public prices in Lebanon, in Lebanese pound according to the following foreign currency rates
 
Drugs Prices According to the Exchange Rate Issued on 10/1/2024
  • Drugs Public Price List according to decision no. 119/1 published in the Official Gazette of 30/01/2020
    
Date Exchange Rate Drugs Public Price
10/1/2024 90,000 LBP Drugs Public Price List
  • Non Subsidized Drugs List issued on 1/2/2023 by Decision No. 119/1 of 26/1/2023, in Particular Article 1 that Stipulates: "The Ministry of Public Health Issues on a daily Basis an Index for the Prices of Unsubsidized Medicines According to the US Exchange Rate on the Parallel Market. The Prices For the Public Shall be in Lebanese Pounds." (You can check the updated prices in the Drugs Public Price List)
Date Non Subsidized Drugs
15/1/2024 Addendum: Non subsidized Drugs List
10/1/2024 Non subsidized Drugs List
  • The list of medicines covered by Resolution 945/1 by Decision No. 119/1 of 26/1/2023, in Particular Article 1 that Stipulates: "The Ministry of Public Health Issues on a daily Basis an Index for the Prices of Unsubsidized Medicines According to the US Exchange Rate on the Parallel Market. The Prices For the Public Shall be in Lebanese Pounds."
 
Date Exchange Rate Medicines covered by Resolution 945/1
10/1/2024 90,000 LBP List of medicines covered by Resolution 945/1
 
 
  • List of conversion of authorized prices of the imported medicine products to public prices in Lebanon, in Lebanese pound according to the following foreign currency rates (FOB)
  • List of conversion of authorized prices of the imported medicine products to public prices in Lebanon, in Lebanese pound according to the following foreign currency rates (FOB)
  • List of conversion of authorized prices of the imported medicine products to public prices in Lebanon, in Lebanese pound according to the following foreign currency rates (CIF)
  • List of conversion of authorized prices of the imported medicine products to public prices in Lebanon, in Lebanese pound according to the following foreign currency rates (CIF)
  • List of conversion of authorized prices of the imported medicine products to public prices in Lebanon, in Lebanese pound according to the following foreign currency rates (Locally Manufactured)
  • List of conversion of authorized prices of the imported medicine products to public prices in Lebanon, in Lebanese pound according to the following foreign currency rates (Locally Manufactured)
  • List of conversion of authorized prices at Hospital of the imported medicine products (Injectable Drugs-Category E1) to public prices in Lebanon, in Lebanese pound according to the following foreign currency rates
  • List of conversion of authorized prices at Hospital of the imported medicine products (Injectable Drugs-Category E2) to public prices in Lebanon, in Lebanese pound according to the following foreign currency rates
 

Drugs Prices Reduction
Lists of Drugs Prices Reduced From 2015 until 2019
 
    4
ATC Name B/G Ingredients Dosage Form Price
J07BC01 HEPATITIS-B VACCINE (r DNA) PAEDIATRIC G Hepatitis B, purified surface antigen adsorbed on aluminium hydroxide (Al+++) (0.25mg to 0.40mg) - 10mcg/0.5ml 10mcg/0.5ml Injectable suspension 323,866 L.L
J07BC02 HAVRIX '1440' B Hepatitis A, inactivated, whole virus - 1,440 ELISA units/ml 1,440 ELISA units/ml Injectable suspension 2,215,996 L.L
J07BC02 HAVRIX JUNIOR 720 B Hepatitis A, inactivated, whole virus - 720 ELISA units/0.5ml 720 ELISA units/0.5ml Injectable suspension 1,491,665 L.L
J07BC02 HEALIVE-HEPATITIS A VACCINE (HUMAN DIPLOID CELL) INACTIVATED BioTech Hepatitis A, inactivated antigen (TZ84 Strain), human diploid cell - 0.5ml/dose 0.5ml/dose Injectable suspension 1,777,904 L.L
J07BC02 HEALIVE-HEPATITIS A VACCINE (HUMAN DIPLOID CELL) INACTIVATED BioTech Hepatitis A, inactivated antigen (TZ84 Strain), human diploid cell - 1ml/dose 0.5ml/dose Injectable suspension 2,257,655 L.L
J07CA09 HEXAXIM BioTech Diphteria Toxoid - ?20IU/0.5ml, Tetanus toxoid - ?40IU/0.5ml, Bordetella Pertussis Antigens: toxoid - 25mcg/0.5ml, Bordetella Pertussis Antigens: filamentous haemagglutinin - 25mcg/0.5ml, Polio virus inactivated type 1 (Mahoney strain) - 40D antigen units/0.5ml, Polio virus inactivated type 2 (MEF-I strain) - 8D antigen units/0.5ml, Polio virus inactivated type 3 (Saukett strain) - 32D antigen units/0.5ml, Hepatitis B, surface antigen - 10mcg/0.5ml, H. Influenza type b polysaccharide1 ,2 - 12mcg/0.5ml, 1 conjugated to tetanus protein - 22-36mcg, 2 adsorbed on aluminium hydroxide hydrated, Al+++ - 0.6mg Injectable suspension 4,509,935 L.L
L01AA06 HOLOXAN B Ifosfamide - 1g 1g Injectable powder for solution 3,586,850 L.L
L01BC05 HAXANIT G Gemcitabine (HCl) - 200mg 200mg Injectable lyophilised powder 1,411,035 L.L
L01BC05 HAXANIT G Gemcitabine (HCl) - 1g 1g Injectable lyophilised powder 6,829,408 L.L
L01CE01 HYCAMTIN IV B Topotecan HCl - 4mg 4mg Injectable lyophilised powder for solution 862,440 L.L
L01CE01 HYCAMTIN IV B Topotecan HCl - 4mg 4mg Injectable lyophilised powder for solution 52,580,031 L.L
L01FD01 HERZUMA BioTech Trastuzumab - 440mg 440mg Injectable powder for concentrate for solution 89,170,219 L.L
L01FD01 HERZUMA BioTech Trastuzumab - 150mg 150mg Injectable powder for concentrate for solution 36,112,482 L.L
L01FD01 HERCEPTIN BioTech Trastuzumab - 440mg 21mg/ml Injectable concentrated powder for solution+diluent 166,423,476 L.L
L01FD01 HERCEPTIN BioTech Trastuzumab - 440mg 21mg/ml Injectable concentrated powder for solution+diluent 166,423,476 L.L
L01FD01 HERZUMA BioTech Trastuzumab - 440mg 440mg Injectable powder for concentrate for solution 1,462,608 L.L
L01FD01 HERZUMA BioTech Trastuzumab - 150mg 150mg Injectable powder for concentrate for solution 15,070,636 L.L
L01XX41 HALAVEN B Eribulin mesylate - 0.88mg/2ml 0.88mg/2ml Injectable solution 6,048,090 L.L
L01XX41 HALAVEN B Eribulin mesylate - 0.88mg/2ml 0.88mg/2ml Injectable solution 36,967,093 L.L
L04AB04 HYRIMOZ BioTech Adalimumab - 40mg 40mg Injectable solution 26,715,144 L.L
L04AB04 HYRIMOZ BioTech Adalimumab - 40mg 40mg Injectable solution 26,715,144 L.L
L04AB04 HUMIRA BioTech Adalimumab - 40mg/0.4ml 40mg/0.4ml Injectable solution 33,860,031 L.L
L04AB04 HYRIMOZ BioTech Adalimumab - 40mg 40mg Injectable solution 682,013 L.L
L04AB04 HYRIMOZ BioTech Adalimumab - 40mg 40mg Injectable solution 682,013 L.L
L04AB04 HUMIRA BioTech Adalimumab - 80mg/0.8ml 80mg/0.8ml Injectable solution 33,860,031 L.L
M01AE03 HUMFINE G Ketoprofen - 100mg/2ml 100mg/2ml Injectable solution 3,514,148 L.L
M09AX01 HYALGAN B Hyaluronic acid (sodium) - 20mg/2ml 20mg/2ml Injectable solution 3,407,985 L.L
N02BE51 HUMACE PLUS G Paracetamol - 500mg, Aceclofenac (potassium) - 200mg Tablet 575,165 L.L
N02BE51 HUMEXLIB PARACETAMOL CHLORPHENAMINE B Paracetamol - 500mg, Chlorphenamine maleate - 4mg Capsule 598,010 L.L
N02BE51 HUMEX RHUME B Pseudoephedrine HCl (tablet) - 60mg, Paracetamol (tablet) - 500mg, Paracetamol (capsule) - 500mg, Chlorphenamine maleate (capsule) - 4mg Tablet, capsule 467,657 L.L
    4
Sitemap
© Copyrights reserved to Ministry of Public Health 2024